里昂共识标准在质子泵抑制剂难治性烧心患者检查中的应用
该研究基于里昂共识的阻抗-pH监测分层诊断方法,对317例未证实胃食管反流病的质子泵抑制剂难治性烧心患者进行停药期阻抗-pH分析,并在96例手术治疗的糜烂性/非糜烂性胃食管反流病患者中进行治疗期术前评估。结果显示,停药期异常酸暴露时间占23%,结合阻抗指标异常可显著增加胃食管反流病证据(从23%升至37%,p<0.0002);治疗期阻抗指标异常提示持续反流者占90%,且3年随访88%患者术后停用质子泵抑制剂后烧心持续缓解。结论认为阻抗-pH监测在质子泵抑制剂难治性烧心的检查中具有高临床价值。
要点
- 停药期阻抗-pH监测中,正常、不确定和异常酸暴露时间分别占59%、17%和23%。
- 结合不确定酸暴露时间与阻抗指标异常,胃食管反流病证据从23%升至37%(p<0.0002)。
- 治疗期阻抗指标异常提示持续反流者占90%,3年随访88%术后停用质子泵抑制剂后烧心持续缓解。
核心结论
- 停药期和治疗期阻抗-pH监测在质子泵抑制剂难治性烧心患者的检查中具有高临床价值。
研究设计与样本
- 专家审阅转诊中心前瞻性评估的未证实胃食管反流病且质子泵抑制剂难治性烧心患者的停药期阻抗-pH监测图谱。
- 评估阻抗指标:总反流次数、反流后吞咽诱导蠕动波指数和平均夜间基线阻抗。
- 专家审阅另一组接受手术治疗的糜烂性/非糜烂性胃食管反流病患者的治疗期术前阻抗-pH监测图谱。
主要发现
- 停药期317例中,正常、不确定和异常酸暴露时间分别占59%、17%和23%。
- 停药期正常酸暴露时间组中高达22%、不确定酸暴露时间组中高达62%的病例通过阻抗指标异常提供胃食管反流病支持证据。
- 将不确定酸暴露时间且阻抗指标异常的病例加入异常酸暴露时间组后,胃食管反流病证据显著增加(从23%升至37%,p<0.0002)。
- 治疗期术前评估96例中,异常/不确定酸暴露时间和阻抗指标超生理值分别显示21%和90%的病例存在持续反流(p<0.00001)。
- 3年随访时88%的病例停用质子泵抑制剂后烧心持续缓解,证实治疗期持续反流与质子泵抑制剂难治性烧心的关系。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A hierarchical approach for gastro-oesophageal reflux disease (GERD) diagnosis by impedance-pH monitoring was proposed by the Lyon Consensus, based on acid exposure time (AET) and supportive impedance metrics. AIMS: To establish the clinical value of Lyon Consensus criteria in the work-up of patients with proton pump inhibitory (PPI)-refractory heartburn. METHODS: Expert review of off-therapy impedance-pH tracings from unproven GERD patients with PPI-refractory heartburn prospectively evaluated at referral centers. Impedance metrics, namely total reflux episodes, postreflux swallow-induced peristaltic wave index, and mean nocturnal baseline impedance, were assessed. Expert review of on-therapy preoperative impedance-pH tracings from a separate cohort of surgically treated erosive/nonerosive GERD cases. RESULTS: Off-therapy, normal, inconclusive, and abnormal AET was found in 59%, 17%, and 23% of 317 cases. Supportive evidence of GERD was provided by abnormal impedance metrics in up to 22% and 62% of cases in the normal and inconclusive AET groups, respectively. Adding the cases with inconclusive AET and abnormal impedance metrics to the abnormal AET group, a significant increase in GERD evidence was observed (from 23% to 37% of cases, p < 0.0002). At the on-therapy presurgical evaluation, abnormal/inconclusive AET and supraphysiological values of impedance metrics showed ongoing reflux in 21% and 90% of 96 cases, respectively (p < 0.00001); a relationship between on-therapy ongoing reflux and PPI-refractory heartburn was confirmed by the favorable surgical outcome at 3-year follow-up, 88% of cases being in persistent off-PPI heartburn remission. CONCLUSIONS: Impedance-pH monitoring, off- and on-therapy, is of high clinical value in the work-up of patients with PPI-refractory heartburn.
引用
- Frazzoni M, Frazzoni L, Ribolsi M, et al. Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn. Aliment Pharmacol Ther. 2022. PMID: 35229321. doi:10.1111/apt.16838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。